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Summary: An antimicrobial stewardship program, consisting of a prescribing 
guideline and point-prevalence surveys with prescriber feedback, was introduced at 
Queen Elizabeth Central Hospital in Malawi. The program was effective in reducing 
third-generation cephalosporin usage and was potentially cost-saving for the hospital. 
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ABSTRACT  
Background: Third-generation cephalosporins (3GC) remain the first-choice empiric 
antibiotic for severe infection in many sub-Saharan African hospitals. In Malawi, 
limited availability of alternatives, mean that strategies to prevent spread of 3GC-
resistance  
(3GC-R) are imperative, however suitable approaches to antimicrobial stewardship 
(AMS) in low-income settings are not well studied. 
Methods: We introduced an AMS intervention to Queen Elizabeth Central Hospital 
(QECH) in Blantyre. The intervention consisted of a smartphone prescribing 
application and regular point-prevalence surveys (PPS) with prescriber feedback. We 
evaluate the effects of the intervention on 3GC usage and on cost of providing 
antibiotics. Using thematic analysis of semi-structured interviews and participant 
observations, we additionally evaluate the acceptability of the stewardship program.  
Results: The proportion of antibiotic prescriptions for a 3GC reduced from 193/241 
(80.1%) to 177/330 (53.6%) (percentage decrease 26.5% [95%CI; 18.7 to 34.1]) with 
no change in case-fatality rate. Cost analysis estimated annual savings of US$15,000. 
Qualitative research revealed trust in the guideline and found its accessibility through 
smartphones helpful to guide clinical decisions. Operational health-system barriers 
and hierarchal clinical relationships lead to continued reliance on 3GC. 
Conclusions: We report the successful introduction of an antimicrobial stewardship 
approach in Malawi. By focusing on pragmatic interventions and simple aims, we 
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demonstrate the feasibility, acceptability and cost-saving of a stewardship program 
where resources  
are limited. In doing so, we provide a suitable starting point for expansion of AMS 
interventions in this and other low-income settings. 
Keywords: antimicrobial resistance, antimicrobial stewardship, Africa south of the 
Sahara,  
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INTRODUCTION 
 
Infection with antimicrobial resistant (AMR) pathogens is associated with high 
morbidity and mortality for patients and a significant economic burden on health 
systems [1, 2]. In sub-Saharan Africa (sSA), the prevalence of AMR in key 
pathogens, is amongst the highest in the world [3] and the mortality burden from 
drug-resistant infections is predicted to be huge [4]. Interventions which reduce 
excessive antimicrobial usage (AMU) have been shown to reduce AMR [5] and 
optimization of AMU is a key WHO target. However, antimicrobial stewardship 
(AMS) programs are typically tailored to high-income settings, frequently 
incorporating specialist infection liaison services, advanced microbiological 
diagnostics and a restrictive antibiotic formulary [5, 6]. Few hospitals in sSA have 
AMS programs in  
place [7] and a better understanding of the ideal components of an effective and 
acceptable AMS intervention in a resource-limited setting is needed. 
 
Ceftriaxone, a parenteral third-generation cephalosporin (3GC), has long been the 
antibiotic of choice in many sub-Saharan African hospitals, its once daily dosing 
regimen and broad-spectrum of activity, making it a useful and convenient choice in 
settings where diagnostics and nursing capacity are limited [8, 9]. In sSA the 
prevalence of 3GC resistance amongst key bloodstream pathogens is high [10] and 
widespread reliance on ceftriaxone has likely been a major driver of this class-level 
resistance [11-13]. 
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In Malawi, sentinel surveillance from patients presenting to Queen Elizabeth Central 
Hospital (QECH) in Blantyre has demonstrated a rapid rise in 3GC-R amongst 
bloodstream Enterobacterales, occurring contemporaneously with the widespread 
roll-out of  
ceftriaxone [14]. Limited availability of alternatives antibiotics, means that reducing 
class-level resistance to cephalosporins and preventing further AMR transmission, is 
of critical importance. AMS is a key strategy for achieving this [15], yet little is 
known about antibiotic prescribing practices at QECH, or what constitute deliverable, 
acceptable and sustainable interventions and targets for an AMS program in a 
resource-poor hospital.  
 
The aim of this work was to establish and evaluate a formal AMS program on the 
adult medical wards at QECH. We conceived and introduced a locally appropriate 
antibiotic guideline and evaluated its impact on ceftriaxone usage and cost of 
antibiotic provision. Incorporating qualitative methodology, we additionally aimed to 
understand the barriers to and enablers of our stewardship approach. 
 
METHODS 
 
Setting 
 
Malawi is a low-income country with low healthcare expenditure (~3% GDP) [16]. 
QECH is a 1300 bed unit and the only hospital providing free inpatient care in 
Blantyre. There are 200 adult medical beds, and ~70% of adult inpatients are HIV-
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infected [17]. Quality assured blood culture and cerebrospinal fluid analysis are 
provided by the Malawi-Liverpool Wellcome Trust Clinical Research Programme 
(MLW), but there is no formal microbiology liaison service. Prior to this study, there 
were no formal AMS activities and no specific antibiotic guideline. 
 
Study design 
 
Overview 
 
The stewardship program had three phases: a pre-implementation prescribing survey, 
designed to identify stewardship targets (January 2016); implementation of an 
antibiotic guideline (June 2016) and two post-implementation prescribing surveys 
(January 2017, January 2018). Point-prevalence surveys (PPS) with feedback to 
prescribers began at the start of the implementation phase and continued for 28-
months. The study methods are described below and in more detail in the 
Supplementary Material. 
 
Antibiotic prescribing surveys 
 
Inpatient records were reviewed to collect data on key stewardship quality indicators. 
The pre-implementation survey was carried out by RL, DK and AK. RL then then 
drafted the antibiotic guideline. Post-implementation surveys were carried out by a 
doctor who was not involved in the implementation phase (KH). We adapted 
standardized stewardship quality indicators to suit local practice [18], focusing on 
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measurable targets such as 48-hour antibiotic review and duration of antibiotic 
prescription (Supplementary Methods, Table 1).  
 
 
 
Stewardship intervention 
 
A series of multidisciplinary team meetings were held to establish the AMS program, 
convening clinicians, nursing managers, hospital directorship, pharmacists and 
microbiologists. All key decisions involved senior clinicians active at QECH. Local 
antimicrobial susceptibility trends, antibiotic availability and national guidelines were 
reviewed and used to design a consensus based antibiotic guideline which was 
reviewed by all senior clinicians in the departments. In Malawi, the burden of severe 
bacterial infection is high and it is critical that AMS does not restrict access to 
potentially lifesaving therapy [19]. Our guideline therefore focused on the importance 
of recognizing and treating sepsis and on 48-hour  antibiotic step down. 
 
The guideline was distributed using booklets, posters and as a smartphone antibiotic 
application, Microguide (http://www.microguide.eu/). Microguide allows prescribers 
to access hospital-specific guidelines on their mobile devices or hospital intranet. The 
QECH version can be viewed at https://viewer.microguide.global/QECH/ADULT4. 
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Point-prevalence surveys 
 
An average of two to three PPS were carried out/month. Two numerators were 
defined in each survey: number of patients on ceftriaxone and number of patients on 
at least one antibiotic. All adult medical inpatients whose notes were available at the 
time of the survey were included and results from each PPS were presented to 
Department of Medicine meetings the following day. These meetings are compulsory 
for all cadres of clinicians and medical students working within the department. 
Results were presented verbally by a study doctor who was clinically active on the 
medical wards. Attendees were informed what proportion of their patients were on 
ceftriaxone and what proportion were on at least one antibiotic and given a reminder 
to review their prescriptions.  
 
Qualitative methods 
 
Semi-structured interviews and observations with clinicians were carried out 
throughout the study (Supplementary Methods). Interviewees were purposively 
sampled based on their role in prescribing antibiotics and observations were 
conducted on medical ward rounds and in morning meetings. Transcripts and field 
notes were imported into Nvivo software package (QSR International Pty Ltd., 
version 11, 2015) and a thematic analysis was conducted.  
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Cost analysis 
 
We explored the impact of the stewardship intervention on the direct health-provider 
costs of supplying antibiotics at QECH. First, we used data captured in the three 
prescribing surveys to estimate the total cost of all antibiotics given to participants in 
each survey. We divided this total cost by the total number of participants in each of 
the three surveys to estimate the average cost/participant. Secondly, we modelled how 
the stewardship intervention would impact on the mean cost/patient and the total 
annual cost of providing antibiotics to those admitted to the three medical wards 
(male medical; female medical; TB ward). We also estimated the annual cost of 
implementing the intervention (Supplementary Table 2). 
 
 
 
Statistical analysis 
 
Stewardship indicators from antibiotic surveys were described as proportions, and 
comparisons between pre -and post-implementation groups done using the 2 test. 
Confidence intervals were calculated using the Wilson method. Assuming that errors 
would be approximately normally distributed, a linear regression model was used to 
detect linear trends in the prevalence of ceftriaxone and all-antibiotic prescriptions 
over time. Seasonality was adjusted for using harmonic terms with a one-year period. 
For the PPS, data were recorded as missing if a patient file was not available at the 
time the survey was carried out. We assumed that missing records were missing at 
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random and therefore not likely to bias the prevalence estimates. Data were analyzed 
using the R statistical package version 3.6.0 (R Foundation for Statistical Computing, 
Vienna, Austria). 
 
Ethics 
 
The study was approved by the Research Ethics Committees of the University of 
Malawi, the College of Medicine (P.10/15/1811) and the Liverpool School of 
Tropical Medicine  
(15-052RS). 
 
RESULTS 
 
The records of 203 patients were reviewed in the pre-implementation survey (Survey 
1). One hundred records were reviewed in the first post-implementation survey 
(Survey 2) and 200 in the second (Survey 3). 
  
Table 1 shows characteristics for all included patients. HIV prevalence was consistent 
across all three surveys (61.2-61.6%), as was recorded ART coverage (79.6-81.4%). 
Median length of hospital stay and in-hospital mortality did not change pre- and post-
intervention (Table 1). Rates of confirmed bloodstream infection ranged between 8.4 
and 13.1%. The most frequently isolated pathogens were as previously reported from 
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QECH [19] and included Salmonella Typhi, Salmonella Typhimurium and Klebsiella 
pneumoniae (Supplementary Results, Table 3). 
 
Clinically suspected focus of infection, as recorded in the medical notes, was similar 
across all surveys (Supplementary Results, Figure 1). Respiratory or central nervous 
system (CNS) infections were the most common syndromes recorded by admitting 
teams, whilst non-focal infection accounted for over 10% of recorded diagnoses. 
Across the three surveys, proportion of records in which a suspected focus of 
infection was not recorded prior to antibiotic administration fell, from 15.3% (Survey 
1) to 6% (Surveys 2 and 3).  
 
A reduction in 3GC usage was seen after implementation of the stewardship program, 
as measured by pre and post-implementation antibiotic surveys (Figure 1, Table 2), 
antibiotic PPS (Figure 2) and median duration of antibiotic prescription (Figure 1, 
Table 2).  
 
The proportion of all antibiotic prescriptions for an intravenous 3GC fell from 
193/241 (80.1%) to 177/330 (53.6%) (percentage decrease 26.5% [95%CI; 18.7 to 
34.1]) 
between the first and last surveys and the median length of ceftriaxone course 
reduced from five to four days (Table 2). This paralleled an increase in clinician 48- 
hour review of antibiotic prescriptions, as documented in the medical notes. Prior to 
the stewardship intervention, only 54/241 (22.4%) of prescriptions showed evidence 
of a 48-hour review, which increased to 242/330 (73.3%) by the final antibiotic 
survey (percentage increase 50.9 [95%CI 43.4 to 58.4]). This and additional key 
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stewardship indicators from the pre- and post-implementation surveys are shown in 
Supplementary Results, Table 4. 
 
The median number of charts included in each PPS was 100 (IQR 94-101). A median 
of 2 files (IQR 2-4) were recorded as missing in each survey. In the first PPS, 78% of 
patients on the ward were receiving ceftriaxone and 86% were receiving at least one 
antibiotic of any class. Figure 2 shows the results of 71 PPS carried out over a period 
of 28-months and a decline in ceftriaxone prescriptions over the study period 
(p<0.01). Although Table 2 shows an increase in ciprofloxacin and metronidazole 
prescriptions across the three prescribing surveys, there was no evidence of a linear 
trend in all-antibiotic prevalence over time  
(p = 0.15) (Figure 2). The coefficients of the harmonic terms in the regression model, 
suggested little evidence of seasonal variation in ceftriaxone usage (p= 0.19 and 
p=0.65 for sin and cosine terms respectively) or in overall antibiotic usage (p=0.62 
and p=0.30 for sine and cosine terms respectively). 
 
The total cost of antibiotics prescribed to patients in Survey 1, Survey 2 and Survey 3 
was US$1907.04, US$584.78 and US$1404.34, respectively. The average cost per 
patient was   US$9.39 (Survey 1), US$5.85 (Survey 2) and US$7.02 (Survey 3) 
(Supplementary Results, Table 5). Table 3 shows the mean cost/patient and total cost 
estimated from modelling the impact of the stewardship program across the three 
adult medical wards at QECH. The mean cost per patient and total costs were lower 
on the TB ward as many patients are admitted to this ward to receive the initial phase 
of TB treatment and the cost of anti-TB drugs were not included here. At patient 
level, the mean cost across the three adult medical wards is projected to fall from 
US$6.79 per patient, to US$5.23 per patient. The total annual cost of providing 
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antibiotics to these three wards is projected to fall from US$67,058.14 to 
US$51,566.60. The total annual cost of delivering the intervention was US$4,358.78 
(Supplementary Methods). 
 
Two rounds of semi-structured interviews were conducted: 20 in the pre-
implementation period and 21 in the post-implementation period. Due to high 
turnover of junior level doctors on the medical wards, only one participant was 
interviewed before and after the guideline introduction. Characteristics of 
interviewees are summarized in Supplementary Results, Table 6. Analysis of 
qualitative data identified six key themes relating to the stewardship intervention: 
facilitators (accessibility of information, trust in guideline content, awareness) and 
barriers (operational barriers, hierarchical relationships and rationalized 
overprescribing). Themes are summarized below and key quotes are presented in 
Table 4. 
 
Facilitators 
 
Theme 1: Accessibility of information  
 
The majority of participants in the post-implementation period reported use of the 
guideline (quotes 1.1 – 1.2) and regular consultation of Microguide was observed 
during ward rounds.  This was in marked contrast to the pre-implementation 
interviews, in which participants cited a range of resources to guide prescribing and 
difficulty in finding locally relevant information (quotes 1.3 – 1.4). Junior level 
doctors in particular, perceived that they now had a new resource which would guide 
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them towards narrow-spectrum antibiotics, and valued the ability to access the 
guideline on their smartphones (quote 1.5).  
 
 
Theme 2: Trust in the guideline content  
 
Most participants felt invested in the guideline, noting the department’s involvement 
in its inception and development (quotes 2.1-2.2). The locally appropriate nature of 
the guidance was cited as crucial in almost all post-implementation interviews, in 
particular with regard to antibiotic availability and pathogen (quotes 2.2-2.4).  
 
Theme 3: Awareness and promotion of stewardship and AMR  
 
The process surrounding introduction of the stewardship intervention was perceived 
to raise awareness of AMR and of overprescribing within the department. Physicians 
of all cadres reported thinking more about their antibiotic prescribing practices than 
before the intervention (quotes 3.1-3.2). 
 
Barriers 
 
Multiple routes to ceftriaxone overprescribing were identified in the thematic analysis 
in the pre- and post-implementation phase. 
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Theme 4: Operational barriers 
 
An overarching theme across interviews and observations was the influence of 
resources on prescribing practices. Limited access to alternative antibiotics (quotes 
4.1-4.3) and comprehensive diagnostics (quotes 4.4), and inadequate nursing capacity 
favoring antibiotics with once-daily dosing regimens (quote 4.5) were frequently 
cited as reasons for ceftriaxone use and overuse as perceived by participants. 
 
Theme 5. Hierarchical relationships and prescribing practice 
 
Hierarchical relationships between the different cadres of clinical staff shaped 
prescribing practices.  Junior team members invariably took direction from senior 
colleagues on prescribing and a rigid hierarchy frequently prohibited junior team 
members from challenging the prescribing of peers or senior colleagues (quotes 5.1-
5.3).  
 
Theme 6: Rationalized overprescribing  
 
Participants frequently described ceftriaxone as the rational choice in the clinical 
situations they faced, with the risk of undertreating individual patients taking priority 
over population level consequences of antibiotic overuse. Junior doctors considered 
intravenous antibiotics to be inherently superior to oral, particularly amongst 
inpatients where the burden of HIV and infection is high (quotes 6.1-6.3). 
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DISCUSSION 
 
We demonstrate that antimicrobial stewardship is feasible and effective in a low-
income country, in a hospital which has no specialist clinical microbiology or ward-
level pharmacy service, a limited antibiotic formulary and no previous ethos of 
stewardship. A locally appropriate, pragmatic antibiotic guideline using smartphone 
technology, supported by a simple educational strategy of weekly ‘reminders’ led to a 
significant reduction in 3GC usage, an increase in the proportion of 48-hour antibiotic 
reviews and a cost-saving of over US$15,000 for the medical wards. Critically, case 
fatality rate did not change in the pre- and post- implementation surveys, nor on the 
medical wards in general during the study period. 
 
Unlike in high-income settings, evidence for successful stewardship in LMICs is 
limited. AMS programs from Cambodia and South Africa have demonstrated 
substantial impact from AMS. However, whilst resource constrained, these settings 
are very different from Malawi, and their stewardship successes relied upon 
established pharmacy infrastructure [20, 21], specialist microbiology liaison [22] and 
a comprehensive formulary [23].   
 
Whilst QECH benefits from sustained access to a quality assured blood culture 
service, we highlight multiple operational barriers to implementing stewardship that 
are distinct to   
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LMICs [24-27], especially reliance on ceftriaxone due to the clinical context: 
critically unwell patients, high burden of infectious disease and limited diagnostics. 
Clinical decision making is not only influenced by guidelines and operational 
constraints; social determinants of prescribing must be understood in order to effect a 
change in practice [28]. Hierarchy and peer pressures shaped antibiotic prescribing 
decisions in our study, as in other settings [26], but these influences have not 
previously been explored in Africa, where qualitative studies of stewardship have 
focused on nursing behaviors [24, 25] and general perceptions of AMR [29]. More in-
depth social research should be undertaken to provide a deeper understanding of the 
mechanisms for changing behavior, if large scale programs are to be successful. 
 
This study has several limitations. Although the PPS show a significant decline in 
prevalence of ceftriaxone usage over the study period, we have limited data from the 
pre-implementation phase. However, previous studies at QECH prior to the 
intervention, have shown ceftriaxone prescribing prevalence of 70-84% [19, 30], 
consistent with our pre-implementation findings.   Further, we did not engage with an 
implementation science framework to guide the design of this first-stage qualitative 
study, which would be a necessary component of a scale up. We have implemented 
an AMS program on adult wards, but pediatric and community level antibiotic usage 
are likely to be major drivers of antibiotic consumption and thus AMR  [31]. Large-
scale stewardship must target these settings next.  
 
We have demonstrated the sustainability of the AMS program over a 28-month 
period, but measuring its long-term impact, whilst essential, is outside the scope of 
this study. The potential cost-saving achieved by the reduction in antibiotic usage is 
key to the sustainability of our program and an antibiotic pharmacist could continue 
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the regular PPS. Involving clinical departments and hospital management in guideline 
development is fundamental to its sustainability. Our guideline is integrated into 
departmental teaching and the Microguide app. provides a function for real-time 
feedback from prescribers, allowing regular updates to be incorporated as often as 
required.  
 
AMS programs in low-income countries are challenged by the dual burden of high 
prevalence of severe and often drug resistant infection, alongside insecure, variable 
access to a range of effective antimicrobials. We demonstrate, that stewardship can be 
adapted to this setting and by focusing on pragmatic interventions and simple targets, 
we show the feasibility, acceptability and cost-saving of a stewardship program in 
Malawi, which was successful in reducing third-generation cephalosporin usage.  In 
doing so, we provide a suitable starting point for expanded, large-scale stewardship 
interventions in this and other resource-limited settings. 
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Abbreviations: ART, antiretroviral therapy; LOS, length of stay 
a
Note that survey 2 was smaller than surveys 1 and 3 because of limited personnel available at 
the time or the survey.  
Table 1. Demographic and outcome data for patients included in the antibiotic 
surveys 
 
 Survey 1 
(n=203) 
Survey 2 
(n=100)
a 
Survey 3  
(n=200) 
Age, median 
(IQR), years 
39 (30-53) 33 (25-45) 40 (30-50) 
Male n/N (%) 102/203 (50.2) 
 
447/100 (47.0) 103/200 (51.5) 
HIV infected n/N 
(%) 
 
122/198 (61.6) 
5 unknown 
 
49/85(57.6)  
15 unknown 
118/193(61.1) 
7 unknown 
On ART if HIV 
infected n/N (%) 
 
98/122 (80.3) 39/49 (79.6) 96/118 (81.4) 
LOS, median 
(IQR), days 
 
7 (4-10) 
 
7 (4-9) 
 
7 (5-12) 
 
In-hospital case-
fatality n/N 
% (95% CI) 
30/193 
15.5 (10.9, 21.6) 
unknown 
outcome=10 
17/100 
17.0 (10.5, 26.1) 
 
22/172 
12.8 (8.4, 18.9) 
unknown 
outcome=8 
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  0 
Table 2.  Antibiotic prescriptions on the medical wards 
 
 Survey 1 Survey 2 Survey 3 
Antibiotic Proportion of 
prescriptions 
 
Number
a
       
% 
Duration, 
days 
 
 
Median 
(IQR) 
Proportion 
of 
prescription
s 
 
Number
a
       
% 
Duration, 
days 
 
 
Median 
(IQR) 
Proportion of 
prescriptions 
 
Number
a
      
% 
Duration, 
days 
 
 
Median 
(IQR) 
3GC
b 193/241 80.1 
 
5.0 (3.0-
8.0) 
80/121 66.1 4.0 (2.0-
7.0) 
177/330 53.6 4.0 (2.0-
7.0) 
Ciprofloxacin 18/241 
 
7.5 4.0 (3.0-
4.0) 
20/121 16.5 6.0 (5.0-
7.0) 
44/330 13.3 3 (1.75-
7.25) 
Amoxicillin 14/241 5.8 
 
3.0 (2.0-
5.0) 
12/121 9.9 5.0 (2.5-
7.0) 
42/330 12.7 3.5 (1.0-
6.0) 
Metronidazole 9/241 
 
3.7 7.0 (5.0-
8.0) 
4/121 3.3 3.0 (2.5-
3.5) 
33/330 10.0 3.0 (2.0-
6.0) 
Flucloxacillin 3/241 0.9 
 
5.0 (3.0-
11.5) 
0 0 - 5/330 1.5 6.0 (1.0-
15.0) 
Erythromycin 2/241 
 
0.8 4.0 (3.0-
4.0) 
0 0 - 1/330 0.3 1 
Benzylpenicillin 1/241 
 
0.4 6.0 1/121 0.8 1 1/330 0.3 12 
Co-amoxiclav 1/241 
 
0.4 6.0 1/120 0.8 3 9/330 2.7 2.0 (2.0-
3.0) 
Doxycycline 0 
 
0 - 2/121 1.7 4.4 (4.25-
4.75) 
2/330 0.6 5 
Gentamicin 0 
 
0 - 1/121 0.8 1 4/330 1.2 1.5 (0-3.5) 
Co-trimoxazole 0 0 
 
- 0 0 - 12/330 3.6 4 (2.75-
5.25) 
All 241 100 4.5 (3.0-
7.0) 
120 100 5.0 (2.0-
7.0) 
330 100 4 (2-6) 
*Total cost 
(US$) 
US$1907.04 US$584.78 US$1404.34 
*Cost per patient 
(US$) 
US$9.39 US$5.85 US$7.02 
Abbreviations: 3CG, third-generation cephalosporin; IQR, inter-quartile range 
a 
Denominator is number of individual antibiotic prescriptions in each survey, not number of patients . An 
individual antibiotic prescription was defined as each prescription written on the patient’s chart. If the 
antibiotic was switched, this was counted as a second prescription.  
b 
Cefotaxime was used in place of ceftriaxone during a period of ceftriaxone shortage in 2017 
*2017 US Dollars 
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Table 3. Estimated health-provider cost of providing antibiotics to medical inpatients in QECH 1 
 2 
 Pre-Stewardship 
program 
(2017 US$) 
Post-Stewardship 
program 
(2017 US$) 
Mean cost per patient (95% CrI): 
TB ward 
Male medical ward 
Female medical ward 
All medical inpatients 
 
5.14 (3.68, 6.59) 
7.31 (6.34, 8.28) 
6.53 (5.54, 7.52) 
6.79 (6.15, 7.44) 
 
4.16 (3.00, 5.31) 
5.90 (5.08, 6.72) 
5.23 (4.45, 6.02) 
5.23 (4.45, 6.01) 
Total cost per annum*:  
TB ward 
Male medical ward 
Female medical ward 
All medical inpatients** 
 
4,313.74 
33,783.43 
25,960.97 
67,058.14 
 
3,491.69 
27,268.02 
20,806.89 
51,566.60 
*based on admissions/year: 840 for TB ward; 4620 for Male medical ward; 3975 for Female medical ward  3 
** total annual cost for all medical inpatients estimated from summing total annual costs for each ward 4 
95% CrI: Credible interval based on  5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
  18 
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Table 4. Quotes from participant interviews and observations, shown by theme 
Theme Participant  Quote 
 
1.  Accessibility 
of information  
 
Registrar, 
Post-
implementation  
 
 
Registrar,  
Post-
implementation 
 
Intern,  
Pre-
implementation 
 
 
 
 
Consultant,  
Pre-
implementation 
 
 
 
 
 
 
 
 
 
 
Consultant,  
Post-
implementation 
 
 
1.1   
 
 
 
 
1.2  
 
 
 
1.3 
 
 
 
 
 
1.4  
 
 
 
 
 
 
 
 
 
 
 
1.5 
 
….due to limited knowledge of antibiotics, I 
would just give a broad spectrum antibiotic, 
because to me that makes me well covered. 
The patient is going to improve….so 
whatever this patient has he is going to 
improve. But now at least I am able to sit 
down and think, what does, what do the 
guidelines say 
 
….for UTI, we used to using ciprofloxacin 
and now they are saying use nitrofurantoin 
and I keep forgetting the dosing because I’ve 
never used it my whole life, this is the first 
time.. Yeah so they do (help). 
 
I remember the time we were switching from 
Cefotaxime to Ceftriaxone nobody knew 
what doses – you may find a meningitis 
patient given Cefotaxime 1g bd, another 
meningitis patient getting 1g Cefotaxime 
TDS, another bacterial meningitis got 1g od 
for about 3 days – which is when I saw the 
patient and changed the dose to the dosage I 
thought was nice. I feel we sometimes lack 
the guidance  
 
… there is so called Malawi standard 
treatment guidelines. There are some 
antibiotic guidelines but no proper antibiotic 
guidelines in queens that we can use as a 
facility as such. We do have a medical 
handbook in our department that we use, and 
it does help us, it does guide us on what 
antibiotics we should give, but it's not very 
detailed. I feel, it's not very specific, it's 
general, at the end of the day it's up to the 
clinician, should I give this antibiotic or not, I 
feel, because of a lack of a proper guideline, 
at times patients are started on the strongest 
antibiotic we have available, that's 
ceftriaxone, I find maybe they don't even 
meet the criteria to have that antibiotic, but 
everyone's on ceftriaxone. I think we don't 
have proper guidelines, in short.  
 
I think the fact that they’ve been made 
available in electronic forms and also there’s 
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a small booklet which you can carry to the 
wards. I think that it’s a step in the right 
direction, I think we should have less excuses 
for not following the guidelines.  
 
2. Trust in the 
content 
 
Consultant,  
Post-
implementation 
 
 
2.1 
 
 
I think we were part of the discussions and 
we were all consulted and told to make 
suggestions of the guidelines 
 
 Consultant,  
Post-
implementation 
 
2.2 
 
So I mean essentially the guidelines are based 
on the data that has been generated over the 
years in terms of the likely the commonest 
organisms that are affecting patients in our 
setting and… we were all consulted and told 
to make suggestions 
 
 Consultant,  
Post-
implementation 
 
2.3 
 
They are realistic guidelines… and what 
they’ve done, is they’ve made sure that most 
of the drugs that are usually in stock are there, 
so they are not some fancy drugs that you can 
hardly find here. 
 
 Registrar,  
Post-
implementation 
 
2.4 In terms of coverage, it covers most of the 
important infections we see in our setting. 
And in terms of management I think it also 
gives us alternative in case one drug is out of 
stock there are always alternatives. 
 
 
3. Awareness 
and promotion 
 
Consultant, Post-
implementation 
 
 
 
 
 
 
 
 
Registrar, Post-
implementation 
 
 
3.1 
 
 
 
 
 
 
 
 
 
3.2 
 
 
I think the only notable change that I can 
comment is on the usage of ceftriaxone, 
because normally we get a report is it on 
every Thursday before the ward round on the 
percentage of ceftriaxone usage in the 
department, so I think from the figures, from 
the initial figures and the current figures it 
seems there has been a significant drop in 
terms of …usage of ceftriaxone. I think now 
not many people they are using ceftriaxone so 
meaning now they are following the 
guidelines so not giving ceftriaxone to each 
and every patient 
 
 
 
Yeah so since I think as a department there 
was quite a lot of awareness and raising  
awareness that we would have the antibiotic 
guidelines 
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4. Operational 
barriers 
 
Registrar, 
Post-
implementation 
 
 
Registrar, 
Pre-
implementation 
 
 
 
Registrar, 
Post-
implementation 
 
 
 
 
Observation,  
Post-
implementation 
 
 
Consultant,  
Post-
implementation 
 
 
 
 
 
4.1 
 
 
 
 
4.2 
 
 
 
 
4.3 
 
 
 
 
 
 
4.4 
 
 
 
 
4.5 
 
Let’s say there’s amoxicillin, but I’d want to 
give something slightly more broad spectrum, 
like augmentin. But there isn’t. And probably 
the next best thing is ceftriaxone. So 
sometimes you use an antibiotic which you 
didn’t necesSArily want to use 
 
One of them is because the oral drug is out of 
stock, so the only choice I had was to give a 
broad spectrum that was IV, but if I had a 
chance I would have given an oral antibiotic. 
It has happened so many times, not once.  
 
 
For example there should be commitment 
from management to ensure that even simpler 
antibiotics should be made readily available 
because even if broad spectrum antibiotics 
only are available and patient has come in 
with simple community acquired pneumonia, 
people may be tempted to use broad spectrum 
antibiotic, because they are only what is 
available. So, I think there should be a 
commitment from the management team to 
ensure that more antibiotics are available 
 
All the (non-infective) neurological cases 
viewed this morning had an infective 
differential. All of these patients had HIV so 
this is not just speculation, it’s a real risk. 
Insufficiency of neuro-imaging means that 
the infective cause cannot be ruled out until 
we get an MRI or the LP or blood culture 
results get back – all of which will be 5 days 
 
When I arrived in 2009, the numbers of 
patients on our wards was really 
horrendous…so there will be one on the bed, 
one on the floor, all the way into the 
corridors. So if you had two trained nurses 
per shift it meant that they would be sitting at 
their desk drawing the antibiotics the whole 
day. …….if they were to do that four times a 
day they did nothing else. So ..patients stared 
getting maybe one dose, or 2  
doses…..but never 4 doses. So we sort of like 
just slowly drifted towards ..once daily 
antibiotics,  ceftriaxone. 
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5. Hierarchical 
relationships 
and prescribing 
practice 
Observation,  
Post-
implementation 
 
 
 
 
 
Medical student,  
Pre-
implementation 
 
 
Registrar,  
Pre-
implementation 
 
5.1 
 
 
 
 
 
 
 
5.2 
 
 
 
5.3 
There is a palpable power dynamic on this 
ward round. … Consultant says out loud we 
should stop ceftriaxone and wrote ‘CSF 
normal, stop ceftriaxone’. He did not look at 
the drug chart and did not cross ceftriaxone 
off. No-on else on ward round crossed off 
…and we moved on to the next patient. 
Certainly, ward round participants don’t seem 
keen to speak unless directly addressed, 
maybe they don’t want to cause disruption to 
the ward round by stopping to cross off 
antibiotic.  
 
But as students when you see the files and 
you see people prescribe amoxicillin, 
ceftriaxone, you think that's the way to go 
because we see people practicing it, but then 
sometimes when you're on ward round you 
see a consultant prescribing an antibiotic 
which you never know is here… 
 
I think the interns who come to the 
department, they see most of the time people 
are on ceftriaxone, so when they are stuck, 
they will think that maybe by giving that, 
they will be off the hook. 
 
6. Rationalized 
overprescribing 
Registrar,  
Pre-
implementation 
 
Consultant, Post-
Intervention 
 
Consultant, Post-
intervention 
 
 
 
6.1 
 
 
6.2 
 
 
6.3 
That could be one possibility, because if I am 
certain you can just give an antibiotic which 
you feel is safe…  
 
And when the patients are perceived to be 
quite unwell, that’s where the problem of 
sticking to the guidelines seems to be an 
issue…. 
 
It basically makes people not to think because 
they have a knee jerk reaction to everyone 
who has a fever, to give them ceftriaxone 
without thinking as to where the focus of 
infection is, so that you can choose an 
appropriate antibiotic for the focus of 
infection. So everyone just gives ceftriaxone 
as a fall-back position. So it stops people 
thinking about what is their ideal treatment in 
this setting. 
 19 
  20 
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FIGURE LEGENDS 21 
 22 
Figure 1. Antibiotic usage pre- and post-implementation, shown as proportions of overall antibiotic 23 
prescriptions in the pre- and post-implementation antibiotic surveys. Survey 1 was pre-24 
implementation and Surveys 2 and 3 were post implementation. 25 
 26 
Figure 2. Point prevalence surveys of ceftriaxone and all antibiotics shown pre- and post-27 
implementation. The antibiotic guideline was launched on 30
th
 June 2016 (shown by dotted line) and 28 
the study period was from 30th January 2016 to 8
th
 June 2018. 29 
 30 
 31 
 32 
 33 
 34 
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 37 
 38 
 39 
 40 
 41 
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Figure 1 43 
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Figure 2 47 
 48 
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